Show simple item record

dc.contributor.authormarycz, Krzysztof
dc.contributor.authorToker, Nezir Yaşar
dc.contributor.authorGRZESIAK, Jakub
dc.contributor.authorSMIESZEK, Agnieszka
dc.contributor.authorNICPON, Jakub
dc.date.accessioned2021-03-04T19:07:09Z
dc.date.available2021-03-04T19:07:09Z
dc.date.issued2014
dc.identifier.citationNICPON J., marycz K., GRZESIAK J., SMIESZEK A., Toker N. Y. , "The Advantages of Autologus Adipose Derived Mesenchymal Stem Cells (AdMSCs) over the Non-steroidal Anti-inflammatory Drugs (NSAIDs) Application for Degenerative Elbow Joint Disease Treatment in Dogs - Twelve Cases", KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, cilt.20, ss.345-350, 2014
dc.identifier.issn1300-6045
dc.identifier.otherav_8e3acd0f-b4eb-4fbc-b7b5-b099edba2d4b
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/96103
dc.identifier.urihttps://doi.org/10.9775/kvfd.2013.10105
dc.description.abstractIn the present study based on clinical case reports, twelve dogs (7 males, 5 females) between the ages of 5 and 11 years old, with clinically diagnosed osteoarthritis of the elbow joint were undertaken for comparison of the therapeutic effect derived from the standard non-steroidal antiinflammatory drug (NSAIDs) treatment with novel, autologous adipose-derived mesenchymal stem cell (AdMSCs) application. Animals were not under any treatment for 3 last months before the diagnosis. Individuals from experimental group were treated with autologous adipose-derived mesenchymal stem cells, while individuals from control group received Mavacoxib (Trocoxil). After 0, 60, 90 and 180 days of the treatment, all individuals were clinically evaluated. Additionally, examination of synovial fluid from all of the animals was performed after 0, 60, 90 and 180 days. The CT analysis were performed at day 0 and 180 days after the treatment. The AdMSCs therapy in the case of elbow joint degeneration (OA) decreased the discomfort and reduced accompanying clinical symptoms like pain, stiffness when walking and lameness. In contrast, though the animals from control group showed the improvement during first period of experiment, the OA symptoms reoccurred 90 days after the application of NSAIDs. This work is the first report that not only describes the picture of clinical examination, but is also based on synovial fluid analysis and CT evaluation. The injections of autologous stem cells did not exhibit any adverse reactions, which confirms the safety of this method. Our research confirmed the efficiency of AdMSC injections for the treatment of elbow joint osteoarthritis in dogs, which improve the clinical picture and the patients' condition, however without the regresses of osteofites.
dc.language.isoeng
dc.subjectTarım ve Çevre Bilimleri (AGE)
dc.subjectVeteriner Bilimleri
dc.subjectVETERİNERLİK BİLİMLERİ
dc.subjectBitki ve Hayvan Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTarımsal Bilimler
dc.titleThe Advantages of Autologus Adipose Derived Mesenchymal Stem Cells (AdMSCs) over the Non-steroidal Anti-inflammatory Drugs (NSAIDs) Application for Degenerative Elbow Joint Disease Treatment in Dogs - Twelve Cases
dc.typeMakale
dc.relation.journalKAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI
dc.contributor.departmentWroclaw University of Environmental & Life Sciences , ,
dc.identifier.volume20
dc.identifier.issue3
dc.identifier.startpage345
dc.identifier.endpage350
dc.contributor.firstauthorID47747


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record